Company Analysis
Sign in

Atossa Therapeutics, Inc. (ATOS)

Nasdaq: ATOS · Pharmaceutical Preparations · Seattle, WA · filing with the SEC since 2010
Full chart Alerts Compare
Grade4.9
◀ Past 4.4● Present 5.6▶ Future 4.5
3 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Income statement, as filed

In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016
Report filedMar 25, 2026Mar 25, 2025Apr 1, 2024Mar 22, 2023Feb 28, 2022Mar 31, 2021Mar 26, 2020Mar 28, 2019Mar 8, 2018Mar 16, 2017
Research and development21,185,00014,117,00017,334,00015,083,0009,210,0006,608,000r6,645,4174,209,9812,328,087770,427
General and administrative15,956,00013,504,00014,043,00012,608,00011,311,0007,999,00010,620,0087,224,2524,859,3696,479,193
Total operating expenses37,141,00027,621,00031,377,00027,691,00020,521,00014,607,000r17,265,42511,434,2337,649,1717,968,590
Operating income-37,141,000-27,621,000-31,377,000-27,691,000-20,521,000-14,607,000r-17,265,425-11,434,233-7,649,171-7,968,590
Interest and investment income2,377,0004,050,0004,343,000877,0006,000·····
Other income (expense), net-6,000-223,000-70,000-146,000-91,000r51,000r25,64829,299154·
Total non-operating income (expense)········1541,599,705
Income before income taxes-34,770,000-25,504,000-30,094,000-26,960,000-20,606,000-17,828,000r-17,239,777-11,404,934-8,122,581-6,368,885
Income tax expense000000000·
Income from continuing operations·········-6,368,885
Net income-34,770,000-25,504,000-30,094,000-26,960,000-20,606,000-17,828,000r-17,239,777-11,404,934-8,122,581-6,368,885
Preferred dividends········2,568,132·
Net income to common shareholders····-20,606,000-22,331,000r-17,239,777-22,884,242-10,690,713-6,368,885
Earnings per share, basic-4.04-3.04r-3.60b-3.15b-2.70b·····
Earnings per share, diluted-4.04-3.04r-3.60b-3.15b······
Earnings per share, basic and diluted····-2.70b-29.55b-30.45b-82.50b-164.55rb-32.40rb
Weighted average shares, basic8,611,3218,390,618r8,405,440b8,441,607rb7,796,667b·····
Weighted average shares, diluted8,611,3218,390,618r8,405,440b8,441,607b······
Weighted average shares, basic and diluted····7,797b754rb566,464b277,183b64,985rb196,485rb
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-15 reverse split of Feb 2026.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense
Total operating expenses the running costs togetherus-gaap:OperatingExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeInterest
Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense
Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Income from continuing operations profit from the businesses it keepsus-gaap:IncomeLossFromContinuingOperations
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Preferred dividends paid to preferred holders before common shareholdersus-gaap:PreferredStockDividendsIncomeStatementImpact
Net income to common shareholders what is left for common shareholdersus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
SI Assistanton ATOS · research, not advice